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Edited by Horst FeldmannAbstract In recent years a substantial body of evidence has
accumulated to support the notion that signaling pathways
known to be important during embryonic development play
important roles in regulating self-renewing tissues. Moreover,
the same pathways are often deregulated during tumorigenesis
due to mutations of key elements of these pathways. The Notch
signaling cascade meets all of the above-mentioned criteria. We
discuss here the pleiotropic roles of the Notch signaling pathway
in three diﬀerent self-renewing organs (intestine, hematopoietic
system and skin) and how its deregulation is involved in tumori-
genesis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Notch signaling; Stem cell; Diﬀerentiation;
Oncogene; Tumor suppressor1. The Notch pathway
The Notch pathway is evolutionarily conserved and found in
organisms as diverse as worms and humans. The consequences
of partial loss-of-function (haplo-insuﬃciency) of the Notch
gene were ﬁrst described in Drosophila in the early 20th century
when fruit ﬂies were observed with notches at the margins of
their wing blades. The gene causing this particular phenotype
was cloned in the mid 1980s (nearly 70 years later) and encodes
a single pass transmembrane (TM) receptor, harboring a large
extracellular domain involved in ligand binding and a cyto-
plasmic domain involved in signal transduction. Drosophila
has one Notch receptor that is bound by two TM bound li-
gands while mammals possess 4 Notch receptors (Notch1–4)
and ﬁve ligands (Jagged1, and 2 and Delta-like 1, 3 and 4)
[1]. The receptors are synthesized as single precursor proteins
that are cleaved during transport to the cell surface where they
are expressed as heterodimers. Notch signaling is initiated by
ligand–receptor interaction between two neighboring cells
resulting in two successive proteolytic cleavages. The ﬁrst isAbbreviations: NICD, Notch intracellular domain; BM, bone marrow;
HSC, hematopoietic stem cell; AGM, aorta-gonad-mesonephreos; TA
cells, transient amplifying cells; Hes, hairy enhancer of split; FoBs,
follicular B cells; MzBs, marginal zone B cells; T-ALL, T cell acute
lymphoblastic leukemia; TAN1, translocation associated Notch homo-
logue; CDKI, cyclin dependent kinase inhibitor; NFAT, nuclear
factors of activated T cells; Shh, sonic hedgehog
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doi:10.1016/j.febslet.2006.03.024mediated by a metalloprotease of the ADAM family (TACE,
tumor necrosis factor-a-converting enzyme), which cleaves
the receptor in the extracellular domain, close to the TM do-
main. The released extracellular domain is then transendocyto-
sed by the ligand-expressing cell. The second cleavage occurs
within the TM domain and is mediated by the c-secretase
activity of a multi-protein complex consisting of presenilin,
nicastrin, APH1 and PEN2 [2]. This ﬁnal cleavage liberates
the cytoplasmic domain of the Notch receptor (NICD), which
subsequently translocates to the nucleus where it binds to its
downstream transcription factor CSL (CBF1 in humans,
Suppressor of Hairless in Drosophila and LAG in Caenorhab-
ditis. elegans, also known as RBP-J in mice) and thereby acti-
vates transcription (Fig. 1). To date only a few Notch target
genes have been identiﬁed, some of which are dependent on
Notch signaling in multiple tissues, while others are tissue spe-
ciﬁc. Members of the basic helix-loop-helix transcription fac-
tor family, Hairy enhancer of split (Hes) are among the best
known Notch target genes. They negatively regulate transcrip-
tion of genes including the achete scute gene family, which is
well known for mediating neuronal diﬀerentiation [3]. Other
Notch target genes include the related Herp (Hes-related
repressor protein) transcription factor family, the cell cycle
regulator Cdkn1a (also known as cyclin dependent kinase
inhibitor (CDKI)p21), the gene for Notch regulated ankyrin
repeat protein (Nrarp), Deltex1 and the pre-T-cell receptor a
gene (reviewed in [1]).
Notch signaling has been shown to regulate a broad range of
events during embryonic and post-natal development, includ-
ing proliferation, apoptosis, border formation, and cell fate
decisions [4]. In self-renewing organs in vertebrates and during
tumorigenesis, inhibition of diﬀerentiation, lineage speciﬁca-
tion at developmental branch points and induction of diﬀeren-
tiation are relevant functions of Notch signaling (Fig. 2). The
ability of the Notch pathway to inhibit diﬀerentiation was ﬁrst
proposed for the nervous and the hematopoietic systems. The
classical example of Notch signaling regulating binary cell fate
decisions at developmental branch points is the development of
the peripheral nervous system in ﬂies. Equipotent precursors
give rise to two alternative cell fates (epidermal versus neuro-
nal) depending on whether an uncommitted progenitor cell re-
ceives a strong Notch signal or not. In a diﬀerent context
(keratinocytes, for example), Notch induces terminal diﬀerenti-
ation (Fig. 2C). Thus, the question arises; how can the Notch
pathway that is not only evolutionarily but also mechanistically
conserved, lead to so many diﬀerent and sometimes opposing
outcomes? One obvious, but also superﬁcial explanation is thatblished by Elsevier B.V. All rights reserved.
Fig. 1. Notch signaling. Notch signaling is initiated between neighboring cells upon ligand receptor interactions resulting in two successive
proteolytic cleavages. The ﬁrst cleavage within the extracellular domain is mediated by TACE, while the second cleavage occurs within the TM
domain is mediated by the c-secretase activity of a multi-protein complex including Presenilins, Nicastrin, APH-1 and PEN-2. The liberated NICD
translocates into the nucleus and heterodimerizes with the transcription factor CSL (CBF1 in humans, Suppressor of hairless in Drosophila and LAG
in C. elegans). This interaction leads to transcriptional activation by displacing co-repressors and simultaneously recruiting co-activators (CoA)
including mastermind-like proteins (such as MAML1).
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standing of the intersecting pathways that interact with and/
or inﬂuence Notch signaling in a given tissue or cell population
to better deﬁne ‘‘context’’. Alternatively, diﬀerent Notch recep-
tors induce diﬀerent gene expression programs or Notch func-
tion might be controlled at the level of Notch ligands. In the
next paragraphs we will discuss examples of various Notch
functions within diﬀerent self-renewing organs and how dereg-
ulation of this pathway contributes to cancer.2. Notch: a gate-keeper of intestinal progenitor cells
The mammalian intestine is a prototype self-renewing organ
as the intestinal epithelium has one of the highest turnover
rates in the body and comprises stem cells, transit amplifying
(TA) cells and terminally diﬀerentiated cells (Fig. 3A). The
gut resembles a tube containing two major parts; the small
and the large intestine, each of which can be further divided
into anatomically diﬀerent structures with diﬀerent functions
(absorption of nutrients and compaction of stools). The small
intestine is much longer in length than the large intestine, and
contains ﬁnger like protrusions called villi that dramatically in-
crease the cell surface area to more eﬃciently absorb nutrients,
as well as invaginations called Crypts of Lieberku¨hn (Fig. 3A).By contrast, the large intestine lacks villi and comprises only
crypts. The epithelia of both comprises four diﬀerent cell lin-
eages: absorptive enterocytes, mucus secreting goblet cells,
hormone secreting enteroendocrine cells and lysozyme and
cryptidin producing Paneth cells (Fig. 3A). For reasons of sim-
plicity we will concentrate on the small intestine. Paneth cells
are the only terminally diﬀerentiated cells found at the bottom
of the crypts. Intestinal stem cells are thought to localize just
above the Paneth cells within the crypts and give rise to prolif-
erating TA cells, which constitute the majority of cells within
the crypt compartment. TA cells migrate upward and stop pro-
liferating upon reaching the top of the crypts where they diﬀer-
entiate into the diﬀerent cell lineages. The enterocytes,
enteroendocrine and goblet cells continue migrating upwards
towards the tips of the villi, and then undergo apoptosis and
are shed into the lumen of the intestine, a process called
exfoliation [5].
Due to the very high turnover rate of the intestinal epithe-
lium, processes such as proliferation, diﬀerentiation, migration
and cell death must be tightly regulated in order to ensure
homeostasis. Despite the diversity of cellular responses, these
processes are apparently controlled by a relatively small num-
ber of signaling pathways, including Wnt, TGFb/BMP,
Hedgehog and Notch. We will focus here on the functions of
the Notch pathway within the intestine. Those readers
Fig. 2. Pleiotropic eﬀects of Notch signaling. The four major roles of the Notch cascade that are relevant within self-renewing tissues or during
tumorigenesis are schematically illustrated. (A) Gate-keeper function: Notch maintains stem and/or TA cells in an undiﬀerentiated state. In the
intestine for example, Notch prevents crypt progenitor cells (TA) from diﬀerentiating. (B) Binary cell fate decisions: In the lymphoid system Notch
speciﬁes the T cell lineage at the expense of the B cell lineage from a (at least) bi-potent early thymocyte progenitor. (C) Induction of diﬀerentiation.
In the skin, Notch induces terminal diﬀerentiation events of TA cells, and during thymocyte diﬀerentiation Notch1 promotes diﬀerentiation of pro-T-
cells into pre-T cells. (D) Tumorigenesis: overexpression of Notch within hematopoietic BM cells or in T cell progenitors results in T cell leukemias
and as such Notch functions as an oncogene. However, in the skin Notch functions as a tumor suppressor since loss of Notch signaling results in the
development of basal cell carcinoma-like tumors.
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referred to other recently published reviews [5,6].
The ﬁrst, direct genetic evidence implicating Notch signaling
in homeostasis of the mammalian intestine derives from induc-
ible gut speciﬁc inactivation of the CSL/RBP-J gene that medi-
ates Notch signaling of all Notch receptors in the mouse.
Postnatal inactivation of CSL/RBP-J within the crypt com-
partment results in the complete loss of proliferating TA cells
followed by their conversion into mucus secreting goblet cells
[7]. In reciprocal experiments expression of a dominant active
form of the Notch1 receptor (NICD) in the gut inhibits diﬀer-
entiation of crypt progenitor cells [8]. The intestines of these
mice consist primarily of undiﬀerentiated TA cells. These reci-
procal loss- and gain-of-function data demonstrate that Notch
functions as a gate-keeper for intestinal crypt progenitor cells
in mice (Fig. 3A). Indirect evidence supporting such an impor-
tant role for Notch is derived from toxicology studies of c-
secretase inhibitors, which are currently being developed by
pharmaceutical companies to inhibit the protease activity (c-
secretase) of the presenilin multi-protein complex for the treat-
ment of Alzheimer’s disease. The primary target of these drugs
is the disease-causing amyloid precursor protein. However
Notch receptors are also cleaved by this protease upon li-
gand-mediated activation resulting in liberation of the NICD
(Fig. 1). However, rodents treated with c-secretase inhibitors
exhibit unwanted side eﬀects such as a large increase in goblet
cells (goblet cell metaplasia) within the crypt compartment due
to the inhibition of Notch signaling [7,9,10]. The fact that loss
of Notch signaling results in goblet cell diﬀerentiation at theexpense of enterocytes suggests an additional function for
Notch signaling in lineage speciﬁcation of enterocytes. Support
for this comes from gene-targeted mice for Hes1 (a well known
Notch target gene). Fetal intestines of Hes1 mutant mice exhi-
bit increased mucus secreting and enteroendocrine cells at the
expense of absorptive enterocytes [11]. The reciprocal pheno-
type is observed in intestines of gene-targeted mice for the
Math1 gene, which is transcriptionally repressed by Hes1 as
their intestines are only populated by enterocytes, suggesting
that Math1 is required for the secretory cell lineages (goblet
and enteroendocrine cells) [6] (Fig. 3A). Taken together these
results indicate that Notch has at least two functions during
intestinal homeostasis; one to maintain undiﬀerentiated crypt
progenitor cells, and the other is to control binary cell fate
decisions of progenitor cells that have to choose between the
secretory and adsorptive cell fates, most likely by Notch in-
duced expression of Hes1.
Another well known signaling cascade that has been impli-
cated in the maintenance of crypt progenitors is the Wnt path-
way. Loss of Wnt signaling in the intestine results in loss of the
proliferative crypt compartment [5]. Thus the Notch and the
Wnt pathways synergize as gate-keepers of self-renewal in
the intestinal epithelium (Fig. 3A).
Recent gene proﬁling experiments have revealed a highly
conserved expression pattern between crypt cell progenitors
and colorectal cancer cells [12]. This symmetry also applies
to the Notch and Wnt pathways as multiple Notch and Wnt
signaling components are expressed both in adenomas of
APC min (multiple intestinal neoplasia) mice as well as in wild
Fig. 3. Notch functions within self-renewing tissues. (A) Notch signaling in the small intestine. Schematic representation of the crypt/villus of the
small intestine. Stem cells (in grey) and transient amplifying (TA) cells (in purple) localize to the crypt compartment, which is maintained by both
Notch and Wnt signaling. All diﬀerentiating TA cells, with exception of Paneth cells which localize to the bottom of the crypt, migrate upwards and
stop cycling at the crypt/villus boundary. Migration of non-proliferating diﬀerentiated cells continues towards the tip of the villus where they are shed
into the lumen of the intestine. One function of Notch signaling within the small intestine is to maintain proliferative crypt progenitors in the
undiﬀerentiated state, while a second function is to inﬂuence a binary cell fate decision of TA cells that have to choose between the adsorptive and the
secretory lineages such as goblet cells and enteroendocrine cells. This process seems to be regulated by the Notch target gene Hes1, which
transcriptionally represses Math1. Math1 is required for the development of secretory lineages while Hes1 expression favors the development of
adsorptive cells. (B) Notch signaling in hematopoiesis. In fetal hematopoiesis, Notch1 signaling is necessary for developing stem cells within the
AGM region. In adult BM progenitors Notch signaling has been proposed (based mainly on gain-of-function studies) to inhibit diﬀerentiation of
stem cells (HSCs). Downregulation of Notch1 signaling is required in BM B cell progenitors to allow normal B cell development. In the thymus
Notch1 signaling is essential for T lineage speciﬁcation in an early thymocyte progenitor, while at subsequent developmental stages it promotes
diﬀerentiation of pro-T cells into pre-T cells of the abT lineage. In the spleen Notch2 signaling speciﬁes MzB. FoBs. (C) Notch signaling in the skin.
Schematic representation of the murine skin showing some proteins that are expressed in speciﬁc cellular layers. The epidermis is a stratiﬁed
squamous epithelium that is composed of multiple cell layers. The basal cell layer localizes to the basement membrane and consists mostly of TA cells
intermingled with a few stem cells. The basal cell layer gives rise ﬁrst to the spinous layer followed by the granular layer and then the corniﬁed layer.
Notch1 signaling induces expression of early diﬀerentiation markers such as Keratin1 and Involucrin, and partially represses the expression of
Loricrin and Filagrin, two late diﬀerentiation markers. Moreover Notch1 induces expression of the cell cycle regulator p21CIP1/WAF by at least two
mechanisms. First, Notch1 targets the p21CIP1/WAF promoter directly, and second Notch1 upregulates p21CIP1/WAF through the activation of
calcineurin/NFAT activity mediated by the downregulation of calcipressin via the Notch target gene Hes1. Both Wnt- and Shh-mediated signaling
are normally repressed in the murine epidermis by Notch1. Repression of the Wnt pathway is at least partially mediated by the downregulation of
Wnt4 through a p21CIP1/WAF:E2F-1-dependent mechanism.
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vation of the Notch and Wnt pathways occurs simultaneously
in proliferating adenomas and intestinal crypts. This leads tothe question whether proliferating adenoma cells can be diﬀer-
entiated and withdrawn from the cell cycle by inhibiting Notch
signaling, similarly to what is observed with crypt progenitors.
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induces goblet cell diﬀerentiation and reduces proliferation in
such adenomas [7], suggesting that speciﬁc inhibition of the
Notch pathway can drive cells out of cycle despite the fact that
Wnt signaling remains active. This ‘proof of principle’ experi-
ment highlights the Notch pathway as potential drug target for
the treatment of intestinal neoplasia.3. Notch and hematopoiesis
The hematopoietic system is certainly the best studied and
characterized self-renewing system. Although hematopoietic
stem cells (HSCs) were ﬁrst identiﬁed 25 years ago [13], the
molecular mechanisms and speciﬁc microenvironments that
regulate self-renewal versus diﬀerentiation are far from being
fully understood. Initially the wide expression pattern of Notch
receptors and their ligands (reviewed in [1]) within the adult
hematopoietic system, suggested that Notch might play an
important role during hematopoiesis. Such a role has been con-
ﬁrmed during embryonic hematopoiesis. In the developing
embryo hematopoiesis starts in the yolk sac, shifts ﬁrst to a re-
gion within the embryo called the aorta-gonad-mesonephros
(AGM), then to the fetal liver and ﬁnally localizes to the bone
marrow (BM) (Fig. 3B). The importance of the Notch pathway
in embryonic hematopoiesis was shown using gene-targeted
mice for Notch1 and Notch2, both of which die around E10.5
due to multiple defects [14]. Hirai and colleagues showed that
while Notch1 is dispensable for primitive hematopoiesis within
the extraembryonic yolk sac, it is essential for the reconstitution
ability of fetal HSCs derived from the AGM region (Fig. 3B).
By contrast, Notch2 appears to be dispensable for both primi-
tive and deﬁnitive embryonic hematopoiesis [14]. During the
onset of deﬁnitive hematopoiesis in the embryo Notch1-RBP-
J-dependent signaling leads to the activation of GATA2 [15],
which has been shown to be an essential transcription factor
for hematopoiesis [16]. The importance of Notch1 for embry-
onic hematopoiesis was further conﬁrmed by generating chime-
ric mice using Notch1 deﬁcient and wild type embryonic stem
cells (ES). Although, hematopoietic cells derived from Notch1
deﬁcient ES cells were initially found in these chimeric embryos,
the level of chimerism declined rapidly. While Notch1 deﬁcient
ES cells contributed eﬃciently to other organ systems, at E15.5
they no longer contributed to the hematopoietic system [17].
Taken together these results underscore the important role of
Notch1 during early embryonic hematopoiesis.
Whether Notch signaling is similarly important for adult
HSC self-renewal and/or maintenance is controversial. The
ﬁrst experiments indirectly supporting an important role for
Notch in HSC maintenance were derived from Notch gain-
of-function studies using hematopoietic cell lines that could
no longer be diﬀerentiated due to the expression of a dominant
active form of the Notch1 receptor (NICD) [18–20]. These re-
sults suggested that Notch inhibits diﬀerentiation of hemato-
poietic progenitor cells. This notion was further conﬁrmed
by similar gain-of-function studies using primary BM progen-
itors which showed increased HCS self-renewal in vivo [21]
(Fig. 3B), and in one case led to immortalization of hemato-
poietic progenitor cells with myeloid and lymphoid diﬀerentia-
tion potential [22]. This enhanced HSC self-renewal is possibly
mediated by Notch1-induced Hes1 expression since trans-
planted Hes1 expressing HSCs resulted in increased numbersof cells with side population activity [23], characterized by
the active eﬄux of the DNA dye Hoechst 33342; a hallmark
of long-term HSCs [24]. Moreover, co-culture assays in which
murine or human HSCs were incubated with immobilized or
soluble Notch ligands, or together with ligand-expressing fee-
der cells maintained or even enhanced HSC self-renewal
in vitro (reviewed in [1]). Recently Duncan et al., retrovirally
expressed a dominant negative form of CSL/RBPJ in HSCs.
These cells showed accelerated diﬀerentiation in vitro and re-
duced levels of chimerism in recipient mice after transplanta-
tion [25]. Although this large body of evidence supports the
notion of an important function for Notch signaling in HSC
self-renewal and/or maintenance, none of the genetic condi-
tional loss-of-function models support this hypothesis. Specif-
ically, neither inducible inactivation of CSL/RBP-J [26], which
mediates Notch signaling of all four Notch receptors, nor con-
ditional loss-of-function of Notch1 [27] or Notch2 [28] in adult
BM cells lead to a HSC phenotype.
Components of the Notch signaling pathway have also been
suggested to participate in the HSC niche, because osteoblast
speciﬁc expression of the activated parathyroid hormone re-
lated protein receptor results in increased Jagged1-expressing
osteoblasts, and correlates with increased HSC numbers.
These data led to the hypothesis that Jagged1-mediated Notch
signaling may regulate HSC homeostasis [29]. However, once
again, the genetic data do not support this hypothesis since
conditional inactivation of Jagged1 in BM progenitors and/
or stroma does not perturb hematopoiesis [30]. Despite the fact
that there is no consensus between gain- and genetic loss-of-
function experiments regarding the role of Notch signaling in
HSC self-renewal and/or maintenance, both experimental set-
tings have demonstrated an essential role for Notch1 in T cell
commitment in the adult lymphoid compartment [1]. Inducible
inactivation of Notch1 in BM progenitors results in a block in
T cell development and ectopic B cell development in the thy-
mus suggesting that Notch1 instructs an early lymphoid pro-
genitor to adopt a T cell fate. In the absence of a Notch1
signal an early lymphoid progenitor chooses the B cell fate
by default (Fig. 3B). An identical phenotype is observed in
mice in which the CSL/RBP-J gene was inactivated in BM pro-
genitors [1], strongly indicating that T cell speciﬁcation is med-
iated by Notch1/RBP-J dependent signaling. Interfering with
Notch signaling by transgenic expression of negative modula-
tors (such as Fringe, Deltex or Nrarp), or dominant negative
forms of transcriptional co-activators (MAML1) also blocks
T cell development concomitant with B-lymphopoiesis in the
thymus (reviewed in [31]). Reciprocal gain-of-function studies
overexpressing NICD in BM progenitors results in ectopic T
cell development at the expense of B cell development [31].
Thus, both gain and loss-of-function studies demonstrate that
Notch1 is essential for T lineage commitment. In addition,
Notch1-RBP-J signaling promotes diﬀerentiation of pro-T
cells into pre-T cells within the thymus by controlling rear-
rangement of the T cell receptor (TCR) b locus [31] through
regulating chromatin accessibility [32], thereby assuring the
successful generation of a pre-TCR complex, which is essential
for thymocyte development (Fig. 3B).
An additional role for Notch signaling has been shown for
splenic B cell diﬀerentiation. Immature BM derived B cells en-
ter the spleen where they diﬀerentiate into either follicular B
cells (FoBs) or marginal zone B cells (MzBs). Notch signaling
is important for MzB diﬀerentiation, a process that is regulated
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[31] (Fig. 3B). Other functions of Notch signaling during adap-
tive immunity are (reviewed in [31]). Taken together the clear
cut physiological roles of Notch signaling in hematopoiesis is
inﬂuencing lineage decision of progenitors at developmental
branch points as well as the induction of diﬀerentiation.4. Notch and T cell neoplasisa
There is increasing evidence that aberrant Notch signaling
plays an important role in a number of cancers (Fig. 2D).
The ﬁrst link between Notch and human tumors was made in
the late 1980s and early 1990s by Jeﬀ Sklar’s group which
cloned and sequenced a t(7;9) chromosomal translocation
breakpoint in a small number of patients suﬀering from T cell
acute lymphoblastic leukemia (T-ALL). The chromosomal
translocation juxtaposes the C-terminal region of EGF-like
repeat 34 of human NOTCH1 to the TCR b-enhancer. This
leads to the expression of a truncated and constitutively active
form of the NOTCH1 receptor which was named TAN1 for
translocation-associated Notch homologue [33]. The causative
role of aberrant Notch signaling for T-cell leukemia was shown
in multiple mouse models by expressing NICD in murine BM
progenitors [34]. Similarly, constitutive expression of Notch1-
ICD or Notch3-ICD in thymocyte progenitors also leads to T
cell leukemia suggesting that the oncogenic potential is not re-
stricted to Notch1 signaling [31]. Moreover these experiments
indicate that not only can NICD transform BM progenitors
(most probably HSCs), it can transform also more committed
thymocyte progenitors. However it is interesting to note that
the oncogenic potential of Notch seems to be restricted to T cell
malignancies as no myeloid malignancies have been reported to
date. The mechanistic reason for this restriction is currently
unknown. It is possible that Notch needs to cooperate with a
T cell speciﬁc signal to cause T cell malignancies. Experiments
supporting this hypothesis are derived from NICD-expressing
BM progenitors from RAG deﬁcient mice (which cannot rear-
range B and TCRs) which do not seem to develop T-ALL, sug-
gesting that Notch cooperates with a TCR-mediated signal [35].
However the molecular details of these TCR-mediated signals
are still not well understood and require further investigation.
The t(7;9) chromosomal translocation in humans occurs
rarely, and is found in less than 1% of all T-ALL patients thus
questioning the clinical importance of this ﬁnding. However in
a recent study, Aster and colleagues identiﬁed activating muta-
tions within the NOTCH1 receptor in more then 50% of the 96
primary T-ALL tumors analyzed. These mutations were found
to localize within the heterodimerization domain and/or PEST
domain, which regulate protein stability of the receptor. In
approximately 20% of cases mutations were found in both
domains [36]. These data show that activating mutations
within the NOTCH1 receptor are one of the major causes
for the development of T cell leukemias thereby pushing Notch
into the center of T-ALL pathology.5. Notch and skin
The skin and its appendages including hair follicles, repre-
sents a physical barrier that is constantly renewed. Two stemcell pools have been described, one in the skin epidermis and
a second in the bulge region of hair follicles. The epidermis con-
sists of multiple layers of keratinocytes that are separated from
the dermis by the basement membrane (Fig. 3C). Slowly cycling
multipotent stem cells, as well as rapidly cycling TA cells are
found within the epidermal basal cell layer that is characterized
by expression of keratins 5 and 14. After a limited number of
cell divisions, TA cells are withdrawn from the cell cycle, and
diﬀerentiate by detaching from the basement membrane to
form the suprabasal spinous layer that expresses keratins 1
and 10. Keratinocytes from the spinous layer continue migrat-
ing towards the outer surface to form the granular layer, char-
acterized by cells that acquire lipid-containing granules that
release their contents in the intercellular space. At this stage
the cells synthesize Filagrin and Loricrin, which participate in
the formation of the corniﬁed envelope in the outermost layer
before eliminating their nuclei and cytoplasmic organelles, a
process called corniﬁcation (Fig. 3C) (reviewed in [37]).
Hair follicles also undergo self-renewal throughout life. Hair
follicle stem cells reside within the bulge region which is lo-
cated in the upper part of the hair follicle at the level of the
insertion of the arrector pili muscle [38]. Hair follicle stem cells
were ﬁrst deﬁned by their label retaining ability [38] and their
capacity to generate hair follicles, sebaceous glands and epider-
mis [39]. Recently very sophisticated studies showed that a sin-
gle cell isolated from the bulge region of either a hair follicle
[40] or a whisker follicle [41], can produce long-term prolifer-
ating clones in vitro, indicating that these cells do indeed have
self-renewal capacity. More importantly, such clonally ex-
panded cells were able to form intact hair follicles and seba-
ceous glands, and to participate in formation of the
epidermis in transplantation experiments, demonstrating that
these cells have multi-lineage potential [40,41]. Moreover, Bar-
randon and colleagues re-isolated hair follicle stem cells from
the ﬁrst transplant and performed serial transplantation exper-
iments thus demonstrating the self-renewal ability of clonally
expanded single hair follicle stem cells in vivo [41].
The multi-lineage potential of bulge stem cells as well the
ability of progeny derived from label retaining cells to contrib-
ute to the epidermis in response to wounding [42] has fueled
the notion that bulge stem cells are also responsible for long-
term self-renewal of the skin epidermis. However a recent
study in which bulge cells were ablated, combined with fate
mapping experiments demonstrated that hair follicle stem cells
are not required for normal homeostasis of the skin epidermis.
However they can contribute transiently to the epidermis after
wounding [43].
In the human epidermis NOTCH1, NOTCH2 and
NOTCH3 show high mRNA expression in the basal cell layer
and weaker expression in the suprabasal layers. Delta1 and
Jagged1 expression is conﬁned to the basal layer [44], with Del-
ta1 expression being highest in regions where potential stem
cells seem to reside. These observations led to the suggestion
that Delta1-mediated Notch signaling induces a TA cell phe-
notype [45]. In the epidermis of newborn mice Notch1 and
Notch2, as well as Jagged1 and Jagged2 are expressed in the
suprabasal layers [46]. Despite these diﬀerences in expression
patterns of Notch receptors and ligands between human and
mouse skin, in vitro data indicate that Notch signaling induces
diﬀerentiation of keratinocytes [45,46]. Activation of Notch1
signaling causes cell cycle arrest in mouse keratinocytes by
increasing expression of the cell cycle regulator p21WAF1/Cip1
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one hand Notch1 induces p21WAF1/Cip1 expression by
directly targeting NICD-RBP-J to the p21 promoter [46], while
on the other hand Notch1 indirectly activates the calcineurin/
nuclear factors of activated T cells (NFAT) pathway, which
acts positively on the p21WAF1/Cip1 TATA-box proximal re-
gion. This indirect activation is mediated by the Notch target
gene Hes1, by downregulating calcipressin, a negative regula-
tor of the serine/threonine phosphatase calcineurin [47]. Acti-
vated calcineurin dephosphorylates NFAT proteins, thereby
inducing their subsequent translocation to the nucleus where
they participate in regulating gene expression programs.
Another property of Notch1 activation in keratinocytes is
induction of early diﬀerentiation markers (such as Keratin1/
10 and Involucrin), down modulation of integrin expression
and partial repression of late diﬀerentiation markers such as
Loricrin and Filagrin [46] (Fig. 3C).
Tissue speciﬁc inactivation of the Notch1, RBP-J and Prese-
nilin1 and 2 genes in the murine epidermis results in hyperpro-
liferation of the skin, hair loss and epidermal cyst formation
within less than one month [48–51]. Moreover, mice in which
Notch1 has been ablated in the skin are more susceptible to
chemical induced carcinogenesis, in part explained by reduced
p21WAF1/Cip1 protein levels [48], since p21WAF1/Cip1/ mice are
also more sensitive to chemical induced carcinogenesis [52].
Since the carcinogen-induced mutation event is predominantly
found within the HA-ras oncogene it is possible that loss of
Notch1 function may have cooperative eﬀects with activated
ras during the transformation process of keratinocytes. Indeed,
if Notch1 deﬁcient keratinocytes forced to express an onco-
genic form of the ras gene are injected subcutaneously into
nude mice they form aggressive squamous cell carcinomas
while wild type control cells do not [48].
Over time, mice with skin speciﬁc inactivation of Notch1
develop spontaneous, highly vascularized, basal cell carci-
noma-like tumors. In mice and humans this tumor type is
frequently associated with aberrant sonic hedgehog (Shh)
signaling, and the absence of Notch1 in the mouse epidermis
leads to aberrant Gli2 expression, a downstream component
of the Shh pathway. Consistent with this, human basal cell
carcinomas show reduced expression of NOTCH1, NOTCH2
and JAGGED1 [44], indicating that loss of NOTCH signal-
ing in the human epidermis could also lead to aberrant Shh
signaling and thus contribute to the development of basal-
cell carcinomas.
The Wnt/b-catenin pathway is another signaling cascade
that is deregulated as a consequence of loss of Notch1 signal-
ing in the mouse skin. Notch1 deﬁciency results in increased b-
catenin mediated signaling in keratinocytes and tumors, while
Wnt signaling can be repressed by activated Notch1 expression
[48]. Suppression of Wnt signaling by Notch1 activation seems
(at least in part) to be mediated indirectly by increasing levels
of p21WAF1/Cip1 protein that subsequently associates with E2F-
1 transcription factors at the Wnt4 promoter causing down
modulation of Wnt4 gene expression [53].
Taken together, the function of Notch signaling in the epi-
dermis and keratinocytes is to induce terminal diﬀerentiation
processes as well as to withdraw proliferating cells from the cell
cycle. A long-term consequence of loss of Notch1 activation in
murine skin is the development of basal-cell carcinoma like tu-
mors, suggesting that the Notch pathway exerts tumor sup-
pressive functions in the skin (Fig. 2D).6. Concluding remarks
The Notch pathway is a key regulator of many developmen-
tal processes during fetal and adult diﬀerentiation. Many of
the general Notch functions such as stem cell gate keeper,
inﬂuencing binary cell fate decisions or induction of terminal
diﬀerentiation processes were ﬁrst described in invertebrates
and subsequently conﬁrmed in self-renewing organ systems
of mammals. Although the Notch pathway is mechanistically
relatively simple and highly conserved its physiological func-
tion within diﬀerent self-renewing tissues is unpredictable de-
spite their common structure. In the intestine Notch and
Wnt play a gate-keeper function for crypt progenitor cells.
In addition Notch seems to inﬂuence binary cell fate decisions
of cells that have to choose between the secretory and adsorp-
tive lineages in the gut. Although deregulation of the Wnt
pathway plays a central oncogenic role in the development
of colorectal cancers in humans it remains to be shown
whether deregulation of Notch signaling also follows the
Wnt cascade in this respect. Although a gate-keeper function
of Notch has also been postulated for HSC in the BM, the best
established role of Notch within the hematopoietic systems is
the ability to inﬂuence and/or specify cell fates of lymphoid
progenitors. Moreover it has become clear that aberrant Notch
signaling in humans due to activating mutations in the
NOTCH1 receptor plays a key role in the development of T-
ALL. Thus Notch1 is an established oncogene in the hemato-
poietic system. However, this dramatically contrasts with the
function of Notch1 in the skin where Notch1 seems to induce
terminal diﬀerentiation processes and moreover functions as a
tumor suppressor. This obviously leads to the question of how
Notch can have such opposing functions in diﬀerent self-
renewing organs. Questions concerning speciﬁc Notch target
genes, mechanistic insights into activating Notch mutations
and cross talk between Notch and other pathways need to be
answered in order to expand our limited understanding of this
‘simple’ signaling pathway.References
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